Skånland SS, Okkenhaug K, Davids MS(2024) PI3K inhibitors in hematology: When one door closes… Clin Cancer Res(in press) DOI 10.1158/1078-0432.CCR-24-0967, PubMed 38967552
Hermansen JU, Yin Y, Rein ID, Skånland SS(2024) Immunophenotyping with (phospho)protein profiling and fluorescent cell barcoding for single-cell signaling analysis and biomarker discovery NPJ Precis Oncol, 8(1), 107 DOI 10.1038/s41698-024-00604-y, PubMed 38769096
Montoya S, Bourcier J, Noviski M, Lu H, Thompson MC, Chirino A, Jahn J, Sondhi AK, Gajewski S, Tan YSM, Yung S, Urban A, Wang E, Han C, Mi X, Kim WJ, Sievers Q, Auger P, Bousquet H, Brathaban N, Bravo B, Gessner M, Guiducci C, Iuliano JN, Kane Tet al.(2024) Kinase-impaired BTK mutations are susceptible to clinical-stage BTK and IKZF1/3 degrader NX-2127 Science, 383(6682), eadi5798 DOI 10.1126/science.adi5798, PubMed 38301010
